Google+ Facebook Twitter Twitter

Tech news: April

This month's top tech news stories

Menarini Diagnostics
Eye control system for digital dissection

Menarini Diagnostics, one of the UK’s leading suppliers of diagnostic equipment, is expanding its comprehensive cellular pathology portfolio with LOOX eye control system for the MacroPATH digital imaging system range.

It is a completely unique solution that allows the biomedical scientist and pathologist to zoom in and out, take images, videos and audio hands-free, only using their eye movements. This new way of working will therefore minimise contamination at the specimens cut up station. LOOX will additionally increase productivity with providing a more intuitive and engaging hands-free user interaction.

LOOX will replace the mouse, keyboard or foot pedal and can be used with glasses, contact lenses or face shields. LOOX is compatible with the MacroPATH imaging system range (MacroPATH, eGROSS and WorkSTATION) so it can be installed on existing customer systems or for any new installations.


Veolia Water Technologies
Purified water

Veolia Water Technologies UK’s PURELAB Quest unit has been selected to provide a complete purified water solution for a newly refurbished laboratory at University College London (UCL). The unit delivers all required types of purified water and was chosen to maximise workspace. Located on the main UCL campus, the Anatomy Building has been undergoing phased updates to much of its interior, including several separate lab areas.



Related Articles

Study advances field of precision medicine

A new method of quickly mapping the genome of single cells, while also clarifying the spatial position of the cells within the body, has been revealed.

DNA in urine for cancer detection

A team of scientists has found that DNA fragments in the urine are not degraded at random or too short to provide any meaningful information.

Genetic risk factor for stroke

Researchers have identified a common genetic variant as a risk factor for stroke – especially in patients older than 65.

Precision genomics in cancer treatments

Scientists have identified genomic signatures in women developing the most common type of breast cancer that can be associated with long-term survival.